Kestra Advisory Services’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.01M | Sell |
|
|||||
|
2025
Q2 | $8.74M | Sell |
|
|||||
|
2025
Q1 | $10.9M | Buy |
|
|||||
|
2024
Q4 | $12M | Buy |
|
|||||
|
2024
Q3 | $14.9M | Sell |
|
|||||
|
2024
Q2 | $19.3M | Buy |
|
|||||
|
2024
Q1 | $16M | Buy |
|
|||||
|
2023
Q4 | $10.4M | Buy |
|
|||||
|
2023
Q3 | $7.29M | Buy |
|
|||||
|
2023
Q2 | $4.07M | Buy |
|
|||||
|
2023
Q1 | $3.68M | Sell |
|
|||||
|
2022
Q4 | $6.46M | Buy |
|
|||||
|
2022
Q3 | $4.23M | Buy |
|
|||||
|
2022
Q2 | $4.42M | Buy |
|
|||||
|
2022
Q1 | $2.45M | Buy |
|
|||||
|
2021
Q4 | $2.12M | Sell |
|
|||||
|
2021
Q3 | $2.19M | Buy |
|
|||||
|
2021
Q2 | $1.64M | Buy |
|
|||||
|
2021
Q1 | $1.31M | Buy |
|
|||||
|
2020
Q4 | $774K | Buy |
|
|||||
|
2020
Q3 | $372K | Buy |
|